U.S. Advances RNAi Research with FDA Approvals and Biotech Funding

agregó una foto Health

2025-06-20 07:42:49

The global RNAi Technology Market was valued at USD 1.6 billion in 2022 and is projected to reach USD 3.6 billion by 2031, growing at a CAGR of 10.3% during the forecast period 2024–2031. RNA interference (RNAi) utilizes small nucleic acid fragments to silence genes post-transcriptionally, enabling the treatment of cancer and other complex disorders with high specificity. This technique...

0 Commentarios 0 Acciones 601 Views 0 Vista previa